Drug Type Monoclonal antibody |
Synonyms CMAB 819, CMAB8-19 |
Target |
Action inhibitors |
Mechanism PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 1 | China | 24 Sep 2020 | |
Recurrent Squamous Cell Carcinoma of the Head and Neck | Phase 1 | China | 24 Sep 2020 | |
Squamous cell carcinoma of head and neck metastatic | Phase 1 | China | 24 Sep 2020 | |
Squamous cell carcinoma of head and neck metastatic | Phase 1 | China | 24 Sep 2020 | |
Hepatocellular Carcinoma | IND Application | China | 11 May 2017 | |
Non-Small Cell Lung Cancer | IND Application | China | 11 May 2017 |